Presented During:
Monday, May 4, 2026: 9:00AM - 4:00PM
McCormick Place Lakeside Center
Posted Room Name:
Exhibit Hall, Poster Area
Abstract No:
P0130
Submission Type:
Abstract Submission
Authors:
Diyar Saeed (1), Orestis Mallis Kyriakides (2), Feras Kabbesh (2), hamid Naraghi (2), Mohamed Zeriouh (2), Andreas Däuwel (2), Bujar Maxhera (2), Diyar Saeed (2)
Institutions:
(1) Heinrich-Heine University Dusseldorf, Krefeld, Germany, (2) Health and Medical University Krefeld, Krefeld, Germany
Submitting Author:
*Diyar Saeed
-
Contact Me
Heinrich-Heine University Dusseldorf
Co-Author(s):
Orestis Mallis Kyriakides
-
Contact Me
Health and Medical University Krefeld
Feras Kabbesh
-
Contact Me
Health and Medical University Krefeld
hamid Naraghi
-
Contact Me
Health and Medical University Krefeld
Mohamed Zeriouh
-
Contact Me
Health and Medical University Krefeld
Andreas Däuwel
-
Contact Me
Health and Medical University Krefeld
Bujar Maxhera
-
Contact Me
Health and Medical University Krefeld
*Diyar Saeed
-
Contact Me
Health and Medical University Krefeld
Presenting Author:
*Diyar Saeed
-
Contact Me
Heinrich-Heine University Dusseldorf
Abstract:
Objectives:
Endoscopic beating-heart tricuspid valve (TV) surgery is increasingly used in cardiac surgery due to improved postoperative outcomes. Traditional approaches require jugular vein cannulation and total CPB with bicaval cannulation. Caval snaring is always required during beating heart TV surgery to avoid air lock. We present our single-center experience using a percutaneously placed novel venous cannula (Smart Canula), allowing minimal invasive TV surgery without additional jugular cannulation and/or caval snaring.The cannula resembles a stent and has multiple penetrations (Figure 1), making air lock a rare occurrence.
Methods:
Thirteen patients underwent beating-heart TV surgery. Preoperative AF was present in 10 patients (six paroxysmal, two persistent, two permanent). Eight patients (mean age 72 ± 10 years; 6 female gender) received a 680 mm cannula, and five (mean age 64 ± 8 years; 2 female gender) a 720 mm cannula. Three patients underwent isolated tricuspid procedures; the remainder had concomitant procedures, including mitral reconstruction in 69 %, cryoablation in 62 %, LAA exclusion in 46 %, and single cases of ASD closure. Three patients underwent redo surgeries after previous cardiac procedures. Mean procedure time was 305 ± 153 min, mean aortic cross-clamp 56 ± 37 min. Tricuspid repair using the clover technique was performed in four patients.
Results:
All procedures were completed without intraoperative air lock. Complications included one re-exploration for bleeding and one intraoperative conversion to sternotomy. Median ICU stay was 5 days, mean hospital stay 17 ± 5 days. Pacemaker implantation was necessary in two patients. Postoperative echocardiography at discharge showed tricuspid valve regurgitation Grade 0 in 45 %, Grade I in 45 %, and Grade II in 18 %. In-hospital mortality was 0 %.
Conclusion:
Endoscopic beating-heart tricuspid repair can be safely performed using a novel percutaneous cannula, eliminating the need for jugular cannulation and/or total CPB with bicaval snaring. No air lock or cannula related complications was observed.
ADULT CARDIAC:
Innovations: New devices or novel approaches, preclinical or clinical
Keywords - Adult
Procedures - Minimally Invasive Procedures/Robotics
Tricuspid Valve - Tricuspid Valve